溴隐亭治疗大泌乳素瘤患者的视觉功能改善

Visual function improvement in patients with macroprolactinomas treated with bromocriptine.

作者信息

Lesser R L, Zheutlin J D, Boghen D, Odel J G, Robbins R J

机构信息

Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Connecticut 06510.

出版信息

Am J Ophthalmol. 1990 May 15;109(5):535-43. doi: 10.1016/s0002-9394(14)70683-x.

DOI:10.1016/s0002-9394(14)70683-x

PMID:2333917

Abstract

We studied eight patients who had visual field defects secondary to prolactin-secreting macroadenomas and who had improved visual function with bromocriptine treatment without surgery or radiation. We recommend bromocriptine as a primary treatment for prolactin-secreting macroadenomas. If therapy is effective, continued regular neuro-ophthalmologic, endocrine, and imaging studies are necessary, because treatment with bromocriptine must be continued indefinitely.

摘要

我们研究了8例因分泌催乳素的大腺瘤而出现视野缺损的患者，这些患者在未接受手术或放疗的情况下，通过溴隐亭治疗视觉功能得到了改善。我们推荐将溴隐亭作为分泌催乳素大腺瘤的主要治疗方法。如果治疗有效，持续定期进行神经眼科、内分泌及影像学检查是必要的，因为必须无限期持续使用溴隐亭进行治疗。